Clinical Trials Logo

Clinical Trial Summary

This research study is evaluating a study product called Briagen™ as a possible treatment for wound healing after Mohs procedure.


Clinical Trial Description

Briagen, the study product being used in this study, is a natural complex carbohydrate wound dressing for skin wounds created by Mohs surgery.

Briagen was developed with the intent to improve healing time and reduce scarring of skin wounds. Briagen seeks to match the mechanical aspects of your skin (thickness, stiffness, hydration, pore size) to assist in the healing process.

The purpose of this research study is to observe healing time of Briagen applied to wounds created as a result of Mohs surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04090970
Study type Observational
Source Gemstone Biotherapeutics
Contact Emily English, PhD
Phone 443-682-7740
Email info@gemstonebio.com
Status Recruiting
Phase
Start date August 26, 2019
Completion date May 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03871478 - Comparing the Efficacy of Local Anesthetics in Mohs Surgery N/A
Withdrawn NCT03485937 - Impact of Videos on Patient Anxiety and Satisfaction N/A
Completed NCT00868088 - Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip Phase 4
Recruiting NCT03586960 - Use of a Novel Device for Stretch Relaxation During Mohs Surgery N/A
Completed NCT03346902 - Study of EB-001 in Facial Scar Reduction Phase 2
Enrolling by invitation NCT06328010 - An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical Centers